Skip to main content

The Kidney and the Sympathetic System: A Short Review

Buy Article:

$68.00 + tax (Refund Policy)

Despite the well documented and very effective non pharmacologic and pharmacologic therapies, hypertension remains often poorly controlled. There is still room for improvements in blood pressure control and recent technological advances have generated a regained interest in the physiopathology of renal sympathetic innervation in hypertension. In this article we review the evidence that renal sympathetic activity is increased in essential hypertension. The postganglionic sympathetic fibers are directed to the afferent and efferent renal arterioles, the juxtaglomerular apparatus, the proximal renal tubule, the loop of Henle, as well as the distal renal tubule and are under the control of many reflex loops, which are summarized in a most comprehensive manner for an unfamiliar reader within this field of research. Studies on renal denervation have provided further insights on the role of the sympathetic system in the kidneys, however their proper interpretation requires a special attention to the experimental protocols, as is explained in the text. Last, the possibility of kidney reinnervation is discussed, as well as the emerging evidence that the kidney is also a sensory organ.

In summary, this review article provides a strong scientific background to understand not only the mechanisms of the hypotensive effects, but also those of possible pitfalls, of renal denervation.

Keywords: Hypertension; kidney; sympathetic

Document Type: Research Article

Publication date: 01 August 2013

More about this publication?
  • Current Clinical Pharmacology publishes frontier reviews on all the latest advances in clinical pharmacology. The journal's aim is to publish the highest quality review articles in the field. Topics covered include: pharmacokinetics; therapeutic trials; adverse drug reactions; drug interactions; drug metabolism; pharmacoepidemiology; and drug development. The journal is essential reading for all researchers in clinical pharmacology.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content